Danaher Leaders Sued Over Waning Call for Virus Tests, Supplies

Danaher Corp.‘s board and top executives maintained false, overly rosy projections about demand for the health-focused conglomerate’s Covid-19 testing products and drug-development equipment despite the disease shifting course, an investor alleges.

The members of leadership, including co-founders Mitchell and Steven Rales, are responsible for harm to the company in 2022 and 2023 as expectations for growth sagged and went into decline, Monique Lanphear says. She filed her derivative suit March 13 in the US District Court for the District of Delaware.

Then-CEO Rainer Blair sold more than $12 million worth of stock, and then-chief financial officer Matthew McGrew sold ...